FI104251B1 - Förfarande för framställning av föreningar för behandling av inflammatoriska tarmsjukdomar - Google Patents

Förfarande för framställning av föreningar för behandling av inflammatoriska tarmsjukdomar

Info

Publication number
FI104251B1
FI104251B1 FI906273A FI906273A FI104251B1 FI 104251 B1 FI104251 B1 FI 104251B1 FI 906273 A FI906273 A FI 906273A FI 906273 A FI906273 A FI 906273A FI 104251 B1 FI104251 B1 FI 104251B1
Authority
FI
Finland
Prior art keywords
inflammatory bowel
compounds
preparation
treatment
benzyl
Prior art date
Application number
FI906273A
Other languages
English (en)
Finnish (fi)
Other versions
FI906273L (fi
FI906273A0 (fi
FI104251B (sv
Inventor
Jaswant Singh Gidda
Jill Ann Panetta
Michael Leroy Phillips
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of FI906273A0 publication Critical patent/FI906273A0/fi
Publication of FI906273L publication Critical patent/FI906273L/fi
Application granted granted Critical
Publication of FI104251B1 publication Critical patent/FI104251B1/sv
Publication of FI104251B publication Critical patent/FI104251B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/14—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/36—Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Surgical Instruments (AREA)
  • Nonmetallic Welding Materials (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Eye Examination Apparatus (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FI906273A 1989-12-21 1990-12-19 Förfarande för framställning av föreningar för behandling av inflammatoriska tarmsjukdomar FI104251B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45420389A 1989-12-21 1989-12-21
US45420389 1989-12-21

Publications (4)

Publication Number Publication Date
FI906273A0 FI906273A0 (fi) 1990-12-19
FI906273L FI906273L (fi) 1991-06-22
FI104251B1 true FI104251B1 (sv) 1999-12-15
FI104251B FI104251B (sv) 1999-12-15

Family

ID=23803709

Family Applications (2)

Application Number Title Priority Date Filing Date
FI906273A FI104251B (sv) 1989-12-21 1990-12-19 Förfarande för framställning av föreningar för behandling av inflammatoriska tarmsjukdomar
FI19991698A FI19991698A7 (sv) 1989-12-21 1999-08-10 Förfarande för selektriv isolering av enantiomererna av racemiska bensylsubstituerade rodaninderivat i väsentligen ren enantiomerisk form

Family Applications After (1)

Application Number Title Priority Date Filing Date
FI19991698A FI19991698A7 (sv) 1989-12-21 1999-08-10 Förfarande för selektriv isolering av enantiomererna av racemiska bensylsubstituerade rodaninderivat i väsentligen ren enantiomerisk form

Country Status (22)

Country Link
EP (1) EP0434394B1 (sv)
JP (1) JP3036853B2 (sv)
KR (1) KR0176243B1 (sv)
CN (1) CN1029846C (sv)
AT (1) ATE169294T1 (sv)
AU (1) AU639734B2 (sv)
CA (1) CA2032330C (sv)
CY (1) CY2100B1 (sv)
DE (1) DE69032537T2 (sv)
DK (1) DK0434394T3 (sv)
ES (1) ES2121748T3 (sv)
FI (2) FI104251B (sv)
HU (1) HU216732B (sv)
IE (1) IE904633A1 (sv)
IL (3) IL108962A (sv)
MX (1) MX23803A (sv)
NO (1) NO300458B1 (sv)
NZ (1) NZ236472A (sv)
PT (1) PT96198B (sv)
RU (2) RU2036915C1 (sv)
YU (1) YU240690A (sv)
ZA (1) ZA9010041B (sv)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU87339A1 (fr) * 1988-09-20 1990-04-06 Oreal Nouveaux derives de benzylidene-cyclanones,leur procede de preparation,leur utilisation en tant qu'agents anti-oxydants et comme filtres solaires,compositions cosmetiques et pharmaceutiques les contenant
US5143928A (en) * 1990-03-27 1992-09-01 Warner-Lambert Company 3,5-di-tertiarybutyl-4-hydroxyphenylmethylene derivatives of 2-substituted thiazolidinones, oxazolidinones, and imidazolidinones as antiinflammatory agents
CZ181493A3 (en) * 1992-09-10 1994-03-16 Lilly Co Eli The use of rhodanine derivative for the preparation of a pharmaceutical composition reducing level of sugar in blood and for treating alzheimer's disease
DK0595546T3 (da) * 1992-10-28 1996-04-15 Shionogi & Co Benzylidenderivater
US6251928B1 (en) * 1994-03-16 2001-06-26 Eli Lilly And Company Treatment of alzheimer's disease employing inhibitors of cathepsin D
US5563277A (en) * 1994-12-21 1996-10-08 Eli Lilly And Company Process for preparing benzyl-substituted rhodanine derivatives
DK0761657T3 (da) * 1995-09-07 2000-08-14 Lilly Co Eli Fremgangsmåde til fremstilling af benzylsubstituerede rhodaninderivater
PE23298A1 (es) * 1995-09-07 1998-05-05 Lilly Co Eli Forma cristalina alternativa de tazofelona
EP0779282A1 (en) * 1995-12-14 1997-06-18 Eli Lilly And Company Thiomorpholinone compounds for treating multiple sclerosis
US5981523A (en) * 1996-02-05 1999-11-09 Eli Lilly And Company Compounds and methods for treating multiple sclerosis
US5773455A (en) * 1996-06-28 1998-06-30 Biomeasure, Incorporated Inhibitors of prenyl transferases
US6063799A (en) * 1996-09-03 2000-05-16 Eli Lilly And Company Alternate crystal form of Tazofelone
US6005142A (en) * 1996-09-03 1999-12-21 Eli Lilly And Company Process for preparing benzyl-substituted rhodanine derivatives
WO2000018748A1 (en) * 1998-09-30 2000-04-06 Roche Diagnostics Gmbh Rhodanine derivatives for the treatment and prevention of metabolic bone disorders
JP2002525362A (ja) * 1998-09-30 2002-08-13 エスヴァイン、アンゲリカ 代謝性骨障害の治療および予防のためのロダニンカルボン酸誘導体
AU6331099A (en) * 1998-09-30 2000-04-17 Roche Diagnostics Gmbh Thiazolidine derivatives for the treatment and prevention of metabolic bone disorders
US7235573B2 (en) 2002-09-30 2007-06-26 The Regents Of The University Of California Methods of treating secretory diarrhea using cystic fibrosis transmembrane conductance regulator protein inhibitors
PL376147A1 (en) * 2002-09-30 2005-12-27 The Regents Of The University Of California Cystic fibrosis transmembrane conductance regulator protein inhibitors and uses thereof
AU2002953533A0 (en) 2002-12-24 2003-01-16 Arthron Limited Fc receptor modulating compounds and compositions
BR112012025343A2 (pt) * 2010-04-15 2016-06-28 Merck Patent Gmbh processo para a preparação de hidroquinonas

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT83152B (pt) * 1985-08-09 1989-03-30 Lilly Co Eli Processo para a preparacao de compostos di-t-butilfenoicos
IE62214B1 (en) * 1988-05-25 1995-01-11 Warner Lambert Co Arylmethylenyl derivatives of thiazolidinones, imidazolidinones and oxazolidinones useful as antiallergy agents and antiinflammatory agents
ZA902520B (en) * 1989-04-07 1991-12-24 Lilly Co Eli Aryl-substituted rhodanine derivatives

Also Published As

Publication number Publication date
IL108962A (en) 1996-12-05
DE69032537T2 (de) 1999-01-21
RU2036915C1 (ru) 1995-06-09
YU240690A (sh) 1992-12-21
RU2050355C1 (ru) 1995-12-20
ATE169294T1 (de) 1998-08-15
DK0434394T3 (da) 1998-12-14
FI906273L (fi) 1991-06-22
DE69032537D1 (de) 1998-09-10
NO905478L (no) 1991-06-24
ZA9010041B (en) 1992-08-26
FI906273A0 (fi) 1990-12-19
KR910011812A (ko) 1991-08-07
CA2032330A1 (en) 1991-06-22
FI19991698L (sv) 1999-08-10
KR0176243B1 (ko) 1999-03-20
NZ236472A (en) 1993-03-26
AU6826690A (en) 1991-06-27
HU908368D0 (en) 1991-07-29
CA2032330C (en) 2001-05-08
IL108962A0 (en) 1994-06-24
NO905478D0 (no) 1990-12-19
HUT59915A (en) 1992-07-28
EP0434394B1 (en) 1998-08-05
FI19991698A7 (sv) 1999-08-10
CN1052668A (zh) 1991-07-03
CN1029846C (zh) 1995-09-27
MX23803A (es) 1994-02-28
HU216732B (hu) 1999-08-30
PT96198A (pt) 1991-09-30
AU639734B2 (en) 1993-08-05
EP0434394A3 (en) 1992-01-08
CY2100B1 (en) 2002-04-05
PT96198B (pt) 1998-05-29
ES2121748T3 (es) 1998-12-16
EP0434394A2 (en) 1991-06-26
JP3036853B2 (ja) 2000-04-24
IL96654A (en) 1995-06-29
FI104251B (sv) 1999-12-15
JPH04279573A (ja) 1992-10-05
IE904633A1 (en) 1991-07-17
NO300458B1 (no) 1997-06-02

Similar Documents

Publication Publication Date Title
FI104251B1 (sv) Förfarande för framställning av föreningar för behandling av inflammatoriska tarmsjukdomar
HUT45247A (en) Process for producing thiazolidinediones with hypolycaemic effect and pharmaceutical compositions comprising the same
NO874350L (no) Fremgangsmaate for fremstilling av antibakterielle forbindelser.
HU912002D0 (en) Process for the production of heterocyclene compounds
NO302414B1 (no) Analogifremgangsmåte for fremstilling av heterocykliske forbindelser
HUT49113A (en) Process for producing 2-/2-hydroxy-3-phenoxy-propyl-amino/-ethyl-phenoxy-methyl-amido derivatives and pharmaceutical compositions containing them as active components
HUT56356A (en) Process for producing thiazolidin-4-ones and 1,3-oxathiolan-5-one derivatives
DE3676922D1 (de) Neue polyoxygenierte labdan-derivate, verfahren zu ihrer herstellung und ihre anwendung als medikamente.
DE69130679D1 (de) Die herstellung von zusammensetzungen zur behandlung von krankheiten der zellproliferation
ATA900589A (de) Stereospezifisches verfahren fuer die herstellung von enantiomeren des 3-substituierten furo (3,4-c) pyridins, so erhaltene enantiomere oder mischungen davon sowie diese enthaltene therapeutische mittel
HUT35680A (en) Process for preparing purine derivatives
EP0583579A3 (en) New 17-hydroxyiminomethyl-5beta, 14beta-androstane derivatives, cardioactive process for their preparation and pharmaceutical preparations thereof.
DK0405442T3 (da) 4,5-Dihydro-6H-imidazo 4,5,1-ij quinolin-6-on-6-oxim-O-sulfonsyrederivater
DE3775496D1 (de) Benzhydryloxyaethyl-piperidine-derivate, verfahren zur herstellung und pharmazeutische zusammenstellungen, die diese enthalten.
EP0799215A4 (en) PROCESS FOR THE PREPARATION OF BENZYL-SUBSTITUTED RHODANINE DERIVATIVES
FR2623501B1 (fr) Nouveaux derives substitues de 20,21-dinoreburnamenine, leur procede de preparation et les nouveaux intermediaires ainsi obtenus, leur application comme medicaments et les compositions pharmaceutiques les renfermant
FI873843A0 (sv) Förfarande för framställning av nya terapeutiskt användbara 4-C-hydroxi-2-r-(substituerad)kroman-4-ättiksyraderivat
ATE13676T1 (de) Delta-1,3,5-3-chlor-11-beta,16-alpha,17-alpha,2 - tetra-(hydroxy)-pregnan-20-on-16,17acetonidderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
NO834759L (no) Fremgangsmaate ved fremstilling av nye 6alfa-methylprednisolonderivater
DE3578065D1 (de) 3-mercapto-2-oxo-1-pyrrolidinessigsaeurederivate, verfahren zur herstellung und pharmazeutische zusammensetzungen die sie enthalten.

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: ELI LILLY AND COMPANY